Marshall Wace, LLP Assertio Holdings, Inc. Transaction History

Marshall Wace, LLP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$0.75 - $1.31 $42,375 - $74,015	56,500 New	56,500 $70,000
Q2 2023 Aug 14, 2023	SELL	$5.0 - $7.66 $3.53 Million - $5.4 Million	-705,133 Reduced 56.72%	538,139 $2.92 Million
Q1 2023 May 15, 2023	BUY	$3.54 - $6.66 $2.03 Million - $3.83 Million	574,738 Added 85.97%	1,243,272 $7.92 Million
Q4 2022 Feb 14, 2023	SELL	$2.11 - $4.3 $434,335 - $885,137	-205,846 Reduced 23.54%	668,534 $2.87 Million
Q3 2022 Nov 14, 2022	SELL	$2.13 - $4.0 $111,754 - $209,868	-52,467 Reduced 5.66%	874,380 $1.99 Million
Q2 2022 Aug 15, 2022	BUY	$1.88 - $3.42 $461,077 - $838,768	245,254 Added 35.98%	926,847 $2.73 Million
Q1 2022 May 16, 2022	BUY	$2.06 - $3.0 $1.22 Million - $1.78 Million	592,996 Added 669.32%	681,593 $1.96 Million
Q4 2021 Feb 14, 2022	BUY	$0.86 - $2.3 $76,193 - $203,773	88,597 New	88,597 $193,000

31M

957K

38.5K

Ticker ASRT
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 48,178,200
Market Cap $39.5M
Description
Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing sp...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.